Diagnosis of gastrointestinal stromal tumors from minute specimens: Cytomorphology, immunohistochemistry, and molecular diagnostic findings

Diagnostic Cytopathology

Volumn 40, Issue 6, 2012, Pages 484-490

  Layfield, Lester J ^a   Wallander, Michelle L ^b  

^a ARUP LABORATORIES   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

activating mutation; fine needle aspiration; gastrointestinal stromal tumor; mutational analysis

Indexed keywords

ASPIRATION BIOPSY; CELL STRUCTURE; CONFERENCE PAPER; DESMOID TUMOR; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MELANOMA; MOLECULAR DIAGNOSIS; MUTATIONAL ANALYSIS; NEURILEMOMA; PRIORITY JOURNAL; PROGNOSIS; SOLITARY FIBROUS TUMOR; TISSUE SECTION;

ANTIGENS, NEOPLASM; BIOPSY, FINE-NEEDLE; CELL NUCLEUS; CYTOPLASM; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; PATHOLOGY, MOLECULAR; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; TETRASPANINS;

EID: 84861574538     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.22838     Document Type: Conference Paper

References (54)

1. Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ,. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: Dependence on anatomic site. Am J Surg Pathol 1999; 23: 82-87.
2. Holden JA, Willmore-Payne C, Layfield LJ,. Gastrointestinal stromal tumors: A guide to the diagnosis. Curr Concepts Gastrointest Pathol 2010; 3: 241-276.
3. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33: 459-465.
4. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH,. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999; 23: 377-389.
5. Rubin BP,. Gastrointestinal stromal tumours: An update. Histopathology 2006; 48: 83-96.
6. Miettinen M, Sarlomo-Rikala M, Lasota J,. Gastrointestinal stromal tumors: Recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213-1220.
7. Miettinen M, Virolainen M, Maarit-Sarlomo-Rikala,. Gastrointestinal stromal tumors-Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol 1995; 19: 207-216.
8. Corless CL, Fletcher JA, Heinrich MC,. Biology of gastrointestinal stromal tumors. J Clin Oncol 2004; 22: 3813-3825.
9. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-805.
10. Isozaki K, Hirota S,. Gain-of-function mutations of receptor tyrosine kinases in gastrointestinal stromal tumors. Curr Genomics 2006; 7: 469-475.
11. Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G,. Clinical management of gastrointestinal stromal tumors: Before and after STI-571. Hum Pathol. 2002; 33: 466-477.
12. Verweij J, Casali PG, Zalcberg J, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: Randomised trial. Lancet 2004; 364: 1127-1134.
13. Miettinen M, Monihan JM, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: Clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999; 23: 1109-1118.
14. Lasota J, Carlson JA, Miettinen M,. Spindle cell tumor of urinary bladder serosa with phenotypic and genotypic features of gastrointestinal stromal tumor. Arch Pathol Lab Med 2000; 124: 894-897.
15. Herrera GA, Pinto de Moraes H, Grizzle WE, Han SG,. Malignant small bowel neoplasm of enteric plexus derivation (plexosarcoma). Light and electron microscopic study confirming the origin of the neoplasm. Dig Dis Sci 1984; 29: 275-284.
16. Carney JA,. The triad of gastric epithelioid leiomyosarcoma, functioning extra-adrenal paraganglioma, and pulmonary chondroma. Cancer 1979; 43: 374-382.
17. Ando N, Goto H, Niwa Y, et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 2002; 55: 37-43.
18. Bardales RH, Stelow EB, Mallery S, Lai R, Stanley MW,. Review of endoscopic ultrasound-guided fine-needle aspiration cytology. Diagn Cytopathol 2006; 34: 140-175.
19. Debol SM, Stanley MW, Mallery JS,. Can fine needle aspiration cytology adequately diagnose and predict the behavior of gastrointestinal stromal tumors? Adv Anat Pathol 2001; 8: 93-97.
20. Wieczorek TJ, Faquin WC, Rubin BP, Cibas ES,. Cytologic diagnosis of gastrointestinal stromal tumor with emphasis on the differential diagnosis with leiomyosarcoma. Cancer 2001; 93: 276-287.
21. Elliott DD, Fanning CV, Caraway NP,. The utility of fine-needle aspiration in the diagnosis of gastrointestinal stromal tumors: A cytomorphologic and immunohistochemical analysis with emphasis on malignant tumors. Cancer 2006; 108: 49-55.
22. Boggino HE, Fernandez MP, Logroño R,. Cytomorphology of gastrointestinal stromal tumor: Diagnostic role of aspiration cytology, core biopsy, and immunochemistry. Diagn Cytopathol 2000; 23: 156-160.
23. Fu K, Eloubeidi MA, Jhala NC, Jhala D, Chhieng DC, Eltoum IE,. Diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration biopsy-A potential pitfall. Ann Diagn Pathol 2002; 6: 294-301.
24. Li SQ, O'Leary TJ, Buchner SB, et al. Fine needle aspiration of gastrointestinal stromal tumors. Acta Cytol 2001; 45: 9-17.
25. Okubo K, Yamao K, Nakamura T, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of gastrointestinal stromal tumors in the stomach. J Gastroenterol 2004; 39: 747-753.
26. Rader AE, Avery A, Wait CL, McGreevey LS, Faigel D, Heinrich MC,. Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit. Cancer 2001; 93: 269-275.
27. Stelow EB, Stanley MW, Mallery S, Lai R, Linzie BM, Bardales RH,. Endoscopic ultrasound-guided fine-needle aspiration findings of gastrointestinal leiomyomas and gastrointestinal stromal tumors. Am J Clin Pathol 2003; 119: 703-708.
28. Dodd LG, Nelson RC, Mooney EE, Gottfried M,. Fine-needle aspiration of gastrointestinal stromal tumors. Am J Clin Pathol 1998; 109: 439-443.
29. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33: 459-465.
30. de Silva CM, Reid R,. Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib. Pathol Oncol Res 2003; 9: 13-19.
31. Badalamenti G, Rodolico V, Fulfaro F, et al. Gastrointestinal stromal tumors (GISTs): Focus on histopathological diagnosis and biomolecular features. Ann Oncol 2007; 18 (Suppl 6): vi136-vi140.
32. Hornick JL, Fletcher CD,. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 2002; 117: 188-193.
33. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299: 708-710.
34. Medeiros F, Corless CL, Duensing A, et al. KIT-negative gastrointestinal stromal tumors: Proof of concept and therapeutic implications. Am J Surg Pathol 2004; 28: 889-894.
35. Miettinen M, Lasota J,. Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006; 130: 1466-1478.
36. Motegi A, Sakurai S, Nakayama H, Sano T, Oyama T, Nakajima T,. PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors. Pathol Int 2005; 55: 106-112.
37. Lee HE, Kim MA, Lee HS, Lee BL, Kim WH,. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining. J Clin Pathol 2008; 61: 722-729.
38. Espinosa I, Lee CH, Kim MK, et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol 2008; 32: 210-218.
39. Roskoski R, Jr,. Signaling by Kit protein-tyrosine kinase-The stem cell factor receptor. Biochem Biophys Res Commun 2005; 337: 1-13.
40. Zhu MJ, Ou WB, Fletcher CD, Cohen PS, Demetri GD, Fletcher JA,. KIT oncoprotein interactions in gastrointestinal stromal tumors: Therapeutic relevance. Oncogene 2007; 26: 6386-6395.
41. Rossi F, Ehlers I, Agosti V, et al. Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor. Proc Natl Acad Sci USA 2006; 103: 12843-12848.
42. Corless CL, Heinrich MC,. Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol 2008; 3: 557-586.
43. Hornick JL, Fletcher CD,. The role of KIT in the management of patients with gastrointestinal stromal tumors. Hum Pathol 2007; 38: 679-687.
44. Kontogianni-Katsarou K, Dimitriadis E, Lariou C, Kairi-Vassilatou E, Pandis N, Kondi-Paphiti A,. KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential. World J Gastroenterol 2008; 14: 1891-1897.
45. Debiec-Rychter M, Sciot R, Le Cesne A, et al; EORTC Soft Tissue and Bone Sarcoma Group; Italian Sarcoma Group; Australasian GastroIntestinal Trials Group. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer 2006; 42: 1093-1103.
46. Heinrich MC, Owzar K, Corless CL, et al. Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. J Clin Oncol 2008; 26: 5360-5367.
47. Heinrich MC, Corless CL, Blanke CD, et al. Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol 2006; 24: 4764-4774.
48. Antonescu CR, Besmer P, Guo T, et al. Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res 2005; 11: 4182-4190.
49. Corless CL, McGreevey L, Haley A, Town A, Heinrich MC,. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 2002; 160: 1567-1572.
50. Morey AL, Wanigesekera GD, Hawkins NJ, Ward RL,. C-kit mutations in gastrointestinal stromal tumours. Pathology 2002; 34: 315-319.
51. Zamò A, Bertolaso A, Franceschetti I, et al. Microfluidic deletion/insertion analysis for rapid screening of KIT and PDGFRA mutations in CD117-positive gastrointestinal stromal tumors: Diagnostic applications and report of a new KIT mutation. J Mol Diagn 2007; 9: 151-157.
52. Willmore C, Holden JA, Zhou L, Tripp S, Wittwer CT, Layfield LJ,. Detection of c-kit-activating mutations in gastrointestinal stromal tumors by high-resolution amplicon melting analysis. Am J Clin Pathol 2004; 122: 206-216.
53. Dong Q, McKee G, Pitman M, Geisinger K, Tambouret R,. Epithelioid variant of gastrointestinal stromal tumor: Diagnosis by fine-needle aspiration. Diagn Cytopathol 2003; 29: 55-60.
54. Li SQ, O'Leary TJ, Sobin LH, Erozan YS, Rosenthal DL, Przygodzki RM,. Analysis of KIT mutation and protein expression in fine needle aspirates of gastrointestinal stromal/smooth muscle tumors. Acta Cytol 2000; 44: 981-986.